Inhibition of Sphingolipid Synthesis as a Phenotype-Modifying Therapy in Cystic Fibrosis.
暂无分享,去创建一个
R. Paroni | R. Ghidoni | M. Piccoli | P. Signorelli | M. Dei Cas | L. Anastasia | A. Mingione | A. Caretti | F. Bonezzi
[1] R. Paroni,et al. An Innovative Lipidomic Workflow to Investigate the Lipid Profile in a Cystic Fibrosis Cell Line , 2020, Cells.
[2] P. Ferroli,et al. Long and Very-Long-Chain Ceramides Correlate with A More Aggressive Behavior in Skull Base Chordoma Patients , 2019, International journal of molecular sciences.
[3] C. Pappone,et al. Sphingolipid Synthesis Inhibition by Myriocin Administration Enhances Lipid Consumption and Ameliorates Lipid Response to Myocardial Ischemia Reperfusion Injury , 2019, Front. Physiol..
[4] W. Lukiw,et al. The Role of Ceramide and Sphingosine-1-Phosphate in Alzheimer’s Disease and Other Neurodegenerative Disorders , 2019, Molecular Neurobiology.
[5] Tamilselvan Jayavelu,et al. Autophagy inhibition by biotin elicits endoplasmic reticulum stress to differentially regulate adipocyte lipid and protein synthesis , 2019, Cell Stress and Chaperones.
[6] Valerio Chiurchiù,et al. Bioactive Lipids and Chronic Inflammation: Managing the Fire Within , 2018, Front. Immunol..
[7] N. Vij,et al. Cigarette Smoke Exposure Inhibits Bacterial Killing via TFEB-Mediated Autophagy Impairment and Resulting Phagocytosis Defect , 2017, Mediators of inflammation.
[8] T. Berzin,et al. The Clinical Implications of Fatty Pancreas: A Concise Review , 2017, Digestive Diseases and Sciences.
[9] M. Falleni,et al. Myriocin treatment of CF lung infection and inflammation: complex analyses for enigmatic lipids , 2017, Naunyn-Schmiedeberg's Archives of Pharmacology.
[10] G. Oh,et al. PPAR-α Activation Mediates Innate Host Defense through Induction of TFEB and Lipid Catabolism , 2017, The Journal of Immunology.
[11] R. Ghidoni,et al. 2-Acetyl-5-tetrahydroxybutyl imidazole (THI) protects 661W cells against oxidative stress , 2017, Naunyn-Schmiedeberg's Archives of Pharmacology.
[12] J. Olzmann,et al. Lipid disequilibrium disrupts ER proteostasis by impairing ERAD substrate glycan trimming and dislocation , 2017, Molecular biology of the cell.
[13] Y. C. Long,et al. FoxO1 interacts with transcription factor EB and differentially regulates mitochondrial uncoupling proteins via autophagy in adipocytes , 2016, Cell Death Discovery.
[14] G. Corso,et al. Reduced absorption and enhanced synthesis of cholesterol in patients with cystic fibrosis: a preliminary study of plasma sterols , 2016, Clinical chemistry and laboratory medicine.
[15] J. Olzmann,et al. Endoplasmic Reticulum-Associated Degradation and Lipid Homeostasis. , 2016, Annual review of nutrition.
[16] C. Angelini,et al. Lipolysis and lipophagy in lipid storage myopathies , 2016, Biochimica et biophysica acta.
[17] M. Falleni,et al. Inhibition of ceramide de novo synthesis by myriocin produces the double effect of reducing pathological inflammation and exerting antifungal activity against A. fumigatus airways infection. , 2016, Biochimica et biophysica acta.
[18] K. Moore,et al. Mycobacterium tuberculosis induces the miR-33 locus to reprogram autophagy and host lipid metabolism , 2016, Nature Immunology.
[19] T. Tatsuta,et al. Lipid droplet–mediated ER homeostasis regulates autophagy and cell survival during starvation , 2016, The Journal of cell biology.
[20] M. Reforgiato,et al. Inhibition of ceramide de novo synthesis as a postischemic strategy to reduce myocardial reperfusion injury , 2016, Basic Research in Cardiology.
[21] Christine C. Wu,et al. VAMP-associated Proteins (VAP) as Receptors That Couple Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Proteostasis with Lipid Homeostasis* , 2016, The Journal of Biological Chemistry.
[22] Thomas A. Lagace. Phosphatidylcholine: Greasing the Cholesterol Transport Machinery , 2016, Lipid insights.
[23] Masanori Arita,et al. MS-DIAL: Data Independent MS/MS Deconvolution for Comprehensive Metabolome Analysis , 2015, Nature Methods.
[24] A. Ballabio,et al. Lysosome: regulator of lipid degradation pathways , 2014, Trends in cell biology.
[25] A. Smerieri,et al. FOXO1 Content Is Reduced in Cystic Fibrosis and Increases with IGF-I Treatment , 2014, International journal of molecular sciences.
[26] T. Lydic,et al. A monophasic extraction strategy for the simultaneous lipidome analysis of polar and nonpolar retina lipids[S] , 2014, Journal of Lipid Research.
[27] A. Bragonzi,et al. Anti-inflammatory action of lipid nanocarrier-delivered myriocin: therapeutic potential in cystic fibrosis. , 2014, Biochimica et biophysica acta.
[28] Ieda Regina Lopes Del Ciampo,et al. Cystic Fibrosis: From Protein-Energy Malnutrition to Obesity with Dyslipidemia , 2013, Iranian journal of pediatrics.
[29] E. Levy,et al. Hypertriglyceridemia is associated with insulin levels in adult cystic fibrosis patients. , 2013, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[30] Andrea Ballabio,et al. Signals from the lysosome: a control centre for cellular clearance and energy metabolism , 2013, Nature Reviews Molecular Cell Biology.
[31] A. Ballabio,et al. TFEB controls cellular lipid metabolism through a starvation-induced autoregulatory loop , 2013, Nature Cell Biology.
[32] J. Mainz,et al. Therapy of CF-Patients with Amitriptyline and Placebo - a Randomised, Double-Blind, Placebo-Controlled Phase IIb Multicenter, Cohort-Study , 2013, Cellular Physiology and Biochemistry.
[33] V. Aidinis,et al. Lysoglycerophospholipids in chronic inflammatory disorders: the PLA(2)/LPC and ATX/LPA axes. , 2013, Biochimica et biophysica acta.
[34] P. Burgel,et al. Liver disease in adult patients with cystic fibrosis: a frequent and independent prognostic factor associated with death or lung transplantation. , 2011, Journal of hepatology.
[35] C. Carlin,et al. Molecular pathways for intracellular cholesterol accumulation: common pathogenic mechanisms in Niemann-Pick disease Type C and cystic fibrosis. , 2011, Archives of biochemistry and biophysics.
[36] Andrea Ballabio,et al. TFEB regulates autophagy: An integrated coordination of cellular degradation and recycling processes , 2011, Autophagy.
[37] Jibin Dong,et al. Sphingomyelin synthase overexpression increases cholesterol accumulation and decreases cholesterol secretion in liver cells , 2011, Lipids in Health and Disease.
[38] A. Ballabio,et al. Cystic fibrosis: A disorder with defective autophagy , 2011, Autophagy.
[39] E. Strettoi,et al. Inhibition of ceramide biosynthesis preserves photoreceptor structure and function in a mouse model of retinitis pigmentosa , 2010, Proceedings of the National Academy of Sciences.
[40] A. Ballabio,et al. Defective CFTR induces aggresome formation and lung inflammation in cystic fibrosis through ROS-mediated autophagy inhibition , 2010, Nature Cell Biology.
[41] S. Previs,et al. Increased plasma membrane cholesterol in cystic fibrosis cells correlates with CFTR genotype and depends on de novo cholesterol synthesis , 2010, Respiratory Research.
[42] G. Pier,et al. Alveolar inflammation in cystic fibrosis. , 2010, Journal of Cystic Fibrosis.
[43] E. Nash,et al. Prevalence of dyslipidemia in adults with cystic fibrosis. , 2010, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[44] T. Worgall,et al. Defective CFTR increases synthesis and mass of sphingolipids that modulate membrane composition and lipid signaling Published, JLR Papers in Press, January 14, 2009. , 2009, Journal of Lipid Research.
[45] R. Crystal,et al. Influence of the cystic fibrosis transmembrane conductance regulator on expression of lipid metabolism-related genes in dendritic cells , 2009, Respiratory research.
[46] T. Worgall. Lipid metabolism in cystic fibrosis , 2009, Current opinion in clinical nutrition and metabolic care.
[47] C. Long,et al. Prolonged administration of a dithiol antioxidant protects against ventricular remodeling due to ischemia-reperfusion in mice. , 2008, American journal of physiology. Heart and circulatory physiology.
[48] V. Villella,et al. Tissue Transglutaminase Activation Modulates Inflammation in Cystic Fibrosis via PPARγ Down-Regulation1 , 2008, The Journal of Immunology.
[49] J. Wakefield,et al. Activation of the unfolded protein response by deltaF508 CFTR. , 2008, American journal of respiratory cell and molecular biology.
[50] M. Weller,et al. Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis , 2008, Nature Medicine.
[51] S. Freedman,et al. Alterations in immune response and PPAR/LXR regulation in cystic fibrosis macrophages. , 2008, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[52] M. Wilschanski,et al. Patterns of GI disease in adulthood associated with mutations in the CFTR gene , 2007, Gut.
[53] P. Walter,et al. Signal integration in the endoplasmic reticulum unfolded protein response , 2007, Nature Reviews Molecular Cell Biology.
[54] N. White,et al. Altered cholesterol homeostasis in cultured and in vivo models of cystic fibrosis. , 2007, American journal of physiology. Lung cellular and molecular physiology.
[55] John R. Riordan,et al. Misassembled mutant ΔF508 CFTR in the distal secretory pathway alters cellular lipid trafficking , 2006, Journal of Cell Science.
[56] W. Warwick,et al. Serum fatty acid profiles in cystic fibrosis patients and their parents , 1994, Lipids.
[57] R. Deckelbaum,et al. Ceramide Synthesis Correlates with the Posttranscriptional Regulation of the Sterol-Regulatory Element-Binding Protein , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[58] E. Parks,et al. Abnormal lipid concentrations in cystic fibrosis. , 2002, The American journal of clinical nutrition.
[59] LA Para,et al. Hepatic insulin resistance and defects in substrate utilization in cystic fibrosis. , 1999, Diabetes.
[60] R. Kronqvist,et al. The rate of sphingomyelin synthesis de novo is influenced by the level of cholesterol in cultured human skin fibroblasts. , 1998, The Biochemical journal.
[61] E. Levy,et al. Circulating tumor necrosis factor-alpha levels and lipid abnormalities in patients with cystic fibrosis. , 1993, Pediatric research.
[62] A. Zwinderman,et al. Cystic fibrosis: MR imaging of the pancreas. , 1991, Radiology.
[63] R. D. Williams,et al. Activities of serine palmitoyltransferase (3-ketosphinganine synthase) in microsomes from different rat tissues. , 1985, Journal of lipid research.
[64] E. Freire,et al. Compositional domain structure in phosphatidylcholine--cholesterol and sphingomyelin--cholesterol bilayers. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[65] J. Gustafson,et al. Cystic Fibrosis , 2009, Journal of the Iowa Medical Society.